Skip to content
10-Q

Quarterly Report

Adicet Bio, Inc. ACET

0001720580-26-000037

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 9.35M sh
Shares Diluted Q1 2026 · Mar 31, 2026 10.74M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 5.69M sh
Capex Q1 2026 · Mar 31, 2026 $37K
Capex Q1 2026 · Mar 31, 2025 $1.49M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$21.49M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$25.4M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $36.25M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $38.92M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $28.13M
Stockholders Equity Q1 2026 · Mar 31, 2026 $140.07M
Stockholders Equity Q1 2026 · Dec 31, 2025 $159.21M
Stockholders Equity Q1 2026 · Mar 31, 2025 $161.45M
Stockholders Equity Q1 2026 · Dec 31, 2024 $186.61M
Current Liabilities Q1 2026 · Mar 31, 2026 $18.3M
Current Liabilities Q1 2026 · Dec 31, 2025 $21.53M
Total Liabilities Q1 2026 · Mar 31, 2026 $29.32M
Total Liabilities Q1 2026 · Dec 31, 2025 $33.15M
Current Assets Q1 2026 · Mar 31, 2026 $140.07M
Current Assets Q1 2026 · Dec 31, 2025 $160.93M
Total Assets Q1 2026 · Mar 31, 2026 $169.38M
Total Assets Q1 2026 · Dec 31, 2025 $192.36M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.88
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$4.96
Eps Basic Q1 2026 · Mar 31, 2026 −$1.88
Eps Basic restated Q1 2026 · Mar 31, 2025 −$4.96
Sga Expense Q1 2026 · Mar 31, 2026 $4.08M
Sga Expense Q1 2026 · Mar 31, 2025 $7.07M
Rd Expense Q1 2026 · Mar 31, 2026 $17.49M
Rd Expense Q1 2026 · Mar 31, 2025 $22.81M
Net Income Q1 2026 · Mar 31, 2026 −$20.24M
Net Income Q1 2026 · Mar 31, 2025 −$28.21M
Operating Income Q1 2026 · Mar 31, 2026 −$21.57M
Operating Income Q1 2026 · Mar 31, 2025 −$29.89M